◀ Back to IL6
APP — IL6
Text-mined interactions from Literome
Derfalvi et al., Cell Biol Int 2000
(Acute-Phase Reaction) :
However, both
IL-6 stimulated junB gene expression ( junB mRNA ) and biosynthesis of type II
APP ( alpha2-macroglobulin, fibrinogen, haptoglobin ) were strongly inhibited by the GH
Verbeek et al., J Histochem Cytochem 2002
:
Both the cytokine interferon-gamma and the lysosomotropic drug chloroquine, but not the cytokines interleukin (IL)-1,
IL-6 , or tumor necrosis factor-alpha (TNF-alpha),
induced an accumulation of
APP in newly formed multivesicular body-like organelles
Milosavljević et al., Gen Physiol Biophys 2003
(Acute-Phase Reaction) :
CCAAT/enhancer binding proteins (C/EBP) alpha, -beta and -delta play an important role in mediating I
interleukin-6 (IL-6) dependent expression of
acute-phase protein (APP) genes in liver during acute-phase ( AP ) response
Shaftel et al., Journal of neuroinflammation 2008
(Alzheimer Disease...) :
The
role of
interleukin-1 in neuroinflammation and
Alzheimer disease : an evolving perspective
Kolkhof et al., Biochem Biophys Res Commun 2010
:
We show here that endogenous and plant derived inhibitors of the Na ( + ) /K ( + ) -ATPase, i.e. the cardiac glycosides ouabain and digitoxin, inhibit IL-1beta- and
IL-6 induced
APP expression in human hepatoma cells and primary human hepatocytes ( PHH ) at nanomolar concentrations
Antonioli et al., J Pharmacol Exp Ther 2010
(Body Weight...) :
APP , EHNA, and dexamethasone counteracted the increments of spleen weight, ameliorated macroscopic and microscopic indexes of inflammation, and
reduced TNF-a,
IL-6 , and MDA levels
Campos et al., J Immunol 1993
:
In growing cultures, the
IL-6 and IL-11 stimulation of thiostatin and hemopexin is
enhanced by TGF-beta, whereas the stimulation of other
APP is reduced
Reiter et al., J Leukoc Biol 1994
:
Neither
ABPP nor tilorone
induced TNF or
IL-6
Gabay et al., Clin Exp Immunol 1995
(Carcinoma, Hepatocellular) :
Since previous studies on the contributions of cytokine inhibitors in connective tissues diseases suggested that IL-1 and tumour necrosis factor-alpha (TNF-alpha) might play an important role in the regulation of CRP, we decided to examine in more detail the respective
roles of IL-1 beta,
IL-6 , and TNF-alpha and their inhibitors in the production of
APP by human primary hepatocytes versus the hepatoma cell line PLC/PRF/5
Schaper et al., FEBS Lett 1997
(Carcinoma, Hepatocellular) :
It was shown that
IL-6 and IL-6-type cytokines activate the so-called JAK/STAT pathway and finally
regulate APP expression in liver cells
Vadas et al., Clin Exp Immunol 1997
:
Although dexamethasone potentiated
IL-6 induced
APP expression in HepG2 cells, it suppressed sPLA2 expression in a dose dependent manner